Results

Total Results: 2,166 records

Showing results for "event".

261. RESPONSE TO REQUEST FOR WORK ASSIGNMENT (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
     December 01, 2009 - Because a medication switch may have been related to an event or an indicator of symptoms that may have … preceded this event, we did not want to attribute those events to exposure to the medications during … Specifically, an individual’s medication exposure was redefined each time there was an event during … Exposure was defined using the 180-day period prior to the day of the event. … controlling for propensity score, to examine the association between medication regimen exposure and risk of event

262. Making Healthcare Safer IV: Final Report on Prioritization of Patient Safety Practices for a New Rapid Review or Rapid Response | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/prioritization-patient-safety-practices
     January 01, 2024 - revised framework Category Item Adverse Drug events: General Medication Topics Computer Adverse Drug Event … systems Rapid response Barcode verification Rapid response Implicit bias training Rapid review Post-event

263. Rapid Response_Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
     November 01, 2024 - ns: CV event ns: all-cause mortality Vrinda, 202131; ESRD; HD; non-controlled trial; 3 months … ↓ Coronary event ↓ CVD ns: All-cause mortality de Souza, 201441; ESRD; HD; Prospective cohort … , time to a coronary event, time to CVD, coronary artery disease, cerebrovascular disease, CV disease … 94% (0.009)** 83% Survival free of coronary event 97% (0.009)** 89% Survival free of CVD 96% (0.037 … 94% (0.009) 83% Survival free of coronary event 97% (0.009) 89% Survival free of CVD

264. Allocation of Scarce Resources During Mass Casualty Events | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/mass-casualty-events-scarce-resources/research
     April 01, 2020 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

265. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - 1 Comparative Effectiveness Review Number 55 Drug Therapy for Rheumatoid Arthritis in Adults: An Update Executive Summary Background Rheumatoid arthritis (RA), which affects 1.3 million adult Americans, is an autoimmune disease that involves inflammation of the synovium (a thin layer of tissue lining a joint …

266. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
     July 01, 2010 - Eligibility criteria, demographics Population Events rates markedly different than in the community Event … Definition ACS acute coronary syndrome EPC Evidence-based Practice Center MACE major adverse cardiac event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

267. Interventions for Breathlessness in Patients With Advanced Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/dyspnea-advanced-cancer/report
     February 01, 2021 - Both nonpharmacological and pharmacological interventions led to adverse event-related dropouts in a

268. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - However, count data or time to event data were not a common enough reported outcome to be considered … A low event rate was not an apriori criterion of withholding the meta-analysis or reporting only CIs … The Stein data can also be added to the section “Participants with at least one adverse event” in the … - On page D-68, participants experiencing an adverse event, and page D- 85, participants experiencing … counted is the one who withdrew due to abnormal labs – abnormal labs would also count as adverse event

269. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
     September 13, 2024 - OR (title: ("long term")) OR (title: ("longer term")) OR (title: (outcomes)) OR (title: ("adverse event … abstract: ("long term")) OR (abstract: ("longer term")) OR (abstract: (outcomes)) OR (abstract: ("adverse event

270. Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stroke-afib-update/research-2018
     May 01, 2020 - Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation:

271. Pain Management Interventions for Elderly Patients With Hip Fracture | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hip-fracture-pain/clinician
     December 01, 2019 - [evidence insufficient] Adverse Events Overall, adverse event rates were similar in both treated

272. BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
     June 01, 2010 - disease burden and changes in clinical practice or population health • Active medical product adverse event … transfusion-associated circulatory overload (TACO) • RiskMAP effectiveness • Evaluation of biomarkers for adverse event … Potential additional issues include anti-trust policies and intellectual property concerns in the event … Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event

273. Atrial-Fibrillation-Addendum-140619 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-addendum-140619.pdf
     June 19, 2014 - AHRQ: CER #119, Treatment of Atrial Fibrillation Report Addendum (Submitted June 13, 2014) All searches run for the AHRQ Comparative Effectiveness Review (CER #119, Treatment of Atrial Fibrillation); found at: http://www.ncbi.nlm.nih.gov/pubmed/24887617 were updated for the Annals of Internal Medicine publicati…

274. Making Healthcare Safer IV: Summary of Findings on Patient Safety Practices and Ratings by a Technical Expert Panel, 2023-2024 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/summary-findings
     December 01, 2024 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

275. Major-Depressive-Disorder Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
     December 01, 2015 - Evidence from meta-analyses of placebo- controlled trials, however, indicated lower overall adverse event

276. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/sodium-potassium/research-protocol
     January 01, 2019 - mortality Stroke, coronary heart disease, myocardial infarction Number of patients with any CVD event … a study reports more than one outcome in this category, we will abstract data for only one type of event … mortality Stroke Coronary heart disease Myocardial infarction Number of patients with any CVD event … mortality Stroke Coronary heart disease Myocardial infarction Number of patients with any CVD event … : e.g., mean/median 24-h urinary excretion, status Outcomes: type and definition (e.g., any CVD event

277. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/nonopioid-chronic-pain/research
     June 01, 2022 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

278. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - significant left ventricular systolic dysfunction, and an increased risk of a major adverse cardiovascular event … Note: ACS = acute coronary syndrome; KQ = Key Question; MACE = major adverse cardiovascular event; MBG … Note: ACS = acute coronary syndrome; CI = confidence interval; MACE = major cardiovascular adverse event … Relative risk (RR): The ratio of an event occurring in an exposed group to an event occurring in a nonexposed … Risk difference (RD): The absolute difference in the event rate between two comparison groups.

279. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - Evidence Yes Yes, OTC meds, NSAIDs, COX-2s, Topicals, Supple-ments Yes, pain relief and risk of CV event

280. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - Specifically, the reported adverse event experience with TMS is now very well established in the two … This adverse event has only been reported in one study, namely, the small study by Berman, et al (2000 … I would like to point out that even in that report the authors noted that this event was shown to be … This event was not present as a device-related adverse event in either of the large, multisite randomized … controlled trials, nor is there any physiologically plausible reason to expect that such an event would